Combination of radiotherapy and sorafenib in recurrent hepatocellular carcinoma: a case report

Yaoru Huang, Shang Wen Chen, Chia-chun Kuo, Jeng-Fong Chiou

研究成果: 雜誌貢獻文章同行評審

摘要

In patients with unresectable hepatocellular carcinoma (HCC), radiotherapy is considered for patients with a large tumor burden or tumors with portal vein tumor thrombosis, which is not indicated for operation or transarterial chemoembolization. Sorafenib has proved to be effective as a first-line treatment for locally advanced and metastatic HCC. Preclinical and clinical studies have shown the efficacy of the combined therapeutic effects of radiotherapy (RT) with sorafenib used either concurrently or sequentially. We presented a patient with multiple recurrent HCCs successfully treated with combined RT and sorafenib.
原文英語
頁(從 - 到)155-158
期刊Case Reports in Clinical Pathology
1
發行號2
出版狀態已發佈 - 2014

指紋

深入研究「Combination of radiotherapy and sorafenib in recurrent hepatocellular carcinoma: a case report」主題。共同形成了獨特的指紋。

引用此